Home › Compare › SPOM vs JNJ

SPOM vs JNJ: Dividend Comparison 2026

SPOM yields 666666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPOM wins by $8.275235618773884e+34M in total portfolio value
10 years
SPOM
SPOM
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full SPOM calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SPOM vs JNJ

📍 SPOM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPOMJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPOM + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SPOM pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPOM
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SPOM beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPOM + JNJ for your $10,000?

SPOM: 50%JNJ: 50%
100% JNJ50/50100% SPOM
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPOM
No analyst data
Altman Z
-367.1
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPOM buys
0
JNJ buys
0
No recent congressional trades found for SPOM or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPOMJNJ
Forward yield666666.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$8.275235618773884e+34M$20.0K ✓
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$8.275075881065991e+34M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPOM vs JNJ ($10,000, DRIP)

YearSPOM PortfolioSPOM Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$66,677,367$66,666,666.67$10,676$355.77+$66.67M → SPOM
2$415,506,651,117$415,435,306,334.37$11,407$389.39+$415506.64M → SPOM
3$2,419,908,598,386,268$2,419,464,006,269,573.00$12,198$426.53+$2419908598.37M → SPOM
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$13,056$467.62+$13171697643084.44M → SPOM
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$13,987$513.12+$67004927492790120.00M → SPOM
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$14,998$563.56+$318562277003514871808.00M → SPOM
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$16,098$619.52+$1.415484168853553e+24M → SPOM
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$17,295$681.69+$5.878130573362507e+27M → SPOM
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$18,599$750.82+$2.2813793009840744e+31M → SPOM
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$20,022$827.78+$8.275235618773884e+34M → SPOM

SPOM vs JNJ: Complete Analysis 2026

SPOM — Stock

Gerpang Healthcare Group operates as a bio-pharmaceutical company that manufactures and sells genetic coating stents, HBV hepatitis B virus vaccines, monoclonal antibodies for male infertility detection, ognitive disorder functional food, and polypeptide probiotics. The company was founded in 2006 and is based in Jinan, China.

Full SPOM Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SPOM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPOM vs SCHDSPOM vs JEPISPOM vs OSPOM vs KOSPOM vs MAINSPOM vs ABBVSPOM vs MRKSPOM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.